Well, alrighty then. Looks like I didn’t win the lottery. So I guess I’ll have to buckle down and write yet another profound but cheeky blog post for this fine long-term care news magazine....
FDA OKs new insulin biosimilar for type 2 diabetes
By
Alicia Lasek
Jul 30, 2021
Semglee is a safe and more cost-effective alternative to the drug Lantus (insulin glargine), the agency announced Wednesday. Semglee does not need a prescriber’s input to be substituted at the pharmacy.
What’s your load? How nurses can lighten med usage
By
Jacqueline Vance, RNC, CDONA/LTC
Jan 23, 2014
The US Food and Drug Administration recently requested that practitioners stop prescribing combination prescription pain medications that have more than 325 mg of acetaminophen per tablet, capsule, etc.,...
FDA approves first biosimilar treatment
By
Elizabeth Newman
Apr 06, 2015
The Food and Drug Administration approved its first biosimilar product in March, opening the door for more costly drug alternatives.
Lawmakers push FDA to take swift action on OTC hearing aids
By
Diane Eastabrook
Apr 12, 2022
A bipartisan team has introduced a bill that orders the FDA to stop dragging its feet and issue a final rule making over-the-counter hearing aids available to consumers.
While FDA moves to halt mask reuse, N95 access remains spotty, report finds
By
Alicia Lasek
Apr 15, 2021
A new push to ensure that healthcare facilities stockpile single-use or reusable N95 respirators has arrived while some workers continue to lack access to the equipment and U.S. mask manufacturers can’t...
FDA approves ‘breakthrough’ therapy for diabetic eye disorder
By
John Hall
Mar 26, 2015
The FDA announced Wednesday that it has granted “breakthrough therapy designation” to the drug Eylea, and expanded its approved use for the treatment of diabetic retinopathy in patients with...
There’s an app for that, but should there be?
By
Elizabeth Newman
Jul 31, 2014
Some apps – like those that are meant to track blood pressure or give medication reminders – are geared toward your future residents. And that’s where the trouble can arise, according...
FDA wants lower doses for sleeping aids
By
Elizabeth Newman
Feb 01, 2013
The Food and Drug Administration is requiring manufacturers of certain sleeping pills, including the widely prescribed Ambien, to reduce current recommended dosages.
LTC pharmacies pivot after feds call for timeout on J&J COVID vaccine
By
Danielle Brown
Apr 14, 2021
Long-term care pharmacies have stopped using the Johnson & Johnson COVID-19 vaccine and are awaiting further instruction from federal health officials, who recommended the halt while they investigate six...